# Sildenafil To Prevent Clot

> **NCT03199612** · EARLY_PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Thrombosis
- Hemolysis

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03199612
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-03
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199612, "Sildenafil To Prevent Clot". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03199612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*